Stoke Therapeutics’ Post

Congrats to Brandon Li and the Power team on their Series A! Excited to be a part of the journey. Here is why Caila Pickett and I got so excited about what they're building – THE consumer marketplace for clinical trials. Current State... 🏥 Over 85% of all clinical trials are delayed due to an inability to recruit enough patients 💉 Patient recruitment is the # 1 reason why research fails 👩⚕️ Enrollment disproportionately impacts women, people of color. and other populations that historically have been excluded from medical research 👨⚕️ Clinical trial recruitment is at an inflection point. Over the past 15 years, the industry has undergone major transformations, creating an environment ripe for innovation, capitalizing on the shift towards patient centricity, wherein patients are truly seen as the ultimate users in clinical research With Power... 📈 Power solves Pharma’s biggest R&D problem – patient recruitment, making it easier for patients to find clinical trial opportunities ⚕ Patients can more easily (1) Discover leading medical researchers with Power's modern search UX and nlp-powered filters (2) Evaluate options using safety and efficacy data, reviews, and researcher testimonials and (3) Match with verified researchers ⏹ Broader participation in clinical research improves scientific understanding of how different demographic groups respond to new treatments and ultimately improve treatment options for people in traditionally underrepresented groups

🌟 I’m Joining Power 🌟 I've stepped onto a path that feels both daunting and exhilarating, leaving behind a team I deeply admire for an opportunity that whispers directly to my soul. The decision to embark on this new adventure wasn’t made lightly, but the pull of making a real difference in a space ripe for transformation was irresistible. 🌍 A Calling That Resonates 🌍 I've joined Power, a company on a transformative mission to democratize medical research access, making strides toward inclusivity for all walks of life, including women, BIPOC, and LGBTQ+ communities that have historically been left out. 🤝 The Reunion Is Sweet 🤝 This move, fueled by a successful Series A raise and a reunion with visionary founders Bask Gill and Brandon Li- marks a pivotal moment to leverage design for meaningful impact. 🙏 Gratitude All Around 🙏 Gratitude is a huge part of this journey. To my colleagues—Brian Shultz, Ken Babcock, Daniel Giovacchini, Leah Marie Walkiewicz, Hannah Cohen (Nickerson), Kassandra Randazzo, Emma Heizer, and Mark Austin—thank you deeply for the opportunity to grow and create memories together. Your support has been foundational to my path. To everyone at Power, including Kamila M., Ed Lui, Bask Gill, Brandon Li, Yucen Zhang, Sara Samson, among others, your warm welcome and unwavering support have made this transition not just smooth but ridiculously exciting. And last, but absolutely not least, Nikhil Basu Trivedi at Footwork, your encouragement and instilling confidence in making the leap has been invaluable. Enough about me, though. I’d love to hear from y’all. If you’ve ever taken a leap for a cause that resonates deeply, how did it shape your journey? #PurposeDrivenDesign #DesignLeadership #DemocratizingMedicine #HealthcareInnovation #MarketplaceDesign

🎉 It's official – we’ve raised a $12M Series A. We’re stoked to be partnering with new leads Kin Ventures and Contrary while deepening our relationship with the team at Footwork. Power started with a mission to reimagine trial recruitment with the patient at its core, and to do something about an outdated system that wasn’t serving anyone effectively. At Power, we’re making it easy for patients and researchers to connect, and data tells us our product is working: 🌐 Over 600,000 patients used Power to discover trials in the last year 🌈 40% of these patients are non-white 💪 A staggering 90% of these patients were previously unconnected with existing research sites We’re excited to celebrate these achievements and many more. Yet, the most impactful milestones are the empowering stories we hear from patients weekly, who have found hope in situations once deemed hopeless. Looking ahead, we're committed to making it easier than ever for all key stakeholders - patients, researchers, and trial sponsors - to connect, and setting a new standard for the clinical trial industry at large. Thank you to everyone who has been a part of this journey. The support we've received over the past 2 years has been nothing short of inspiring. And finally, a shout out to some of our awesome investors who we are partnering with on this round: Nikhil Basu Trivedi and Mike Smith at Footwork Tina Hoang-To at Kin Ventures Megan Kao, Eric Tarczynski and Kyle Harrison at Contrary Daniel Rumennik and Lenny Rachitsky at AirAngels Vasudev Bailey and Stuart Peterson at ARTIS Ventures Harry Stebbings, Casey Winters and Rob Schutz at 20Growth Ryan Ackell at 14W Tim Kendall and Evan Tato at Common Metal Terrence Rohan at Otherwise

Last week, we welcomed Mark Melton, MSc to our team! As the founder of ClearPath Biomarker Ops, Mark brings a wealth of expertise to Slope and will be essential in helping our team develop the first-ever end-to-end solution for #clinicaltrialexecution. We were able to sit down with him this week and discuss his previous experience in the #clinicaltrials industry, what he thinks the biggest challenges in #clinicalresearch are, and where he sees this next chapter leading for Slope. #clinicalinnovation

🚨 A good reminder to all my MedTech and Digital Health startup colleagues and clients. This is a big deal, showing that you are doing your due diligence to avoid bias will be something more and more VC's will want to see before investing future $$$. https://lnkd.in/gsGHwYtu

An exciting conversation during the Roundtable on "Driving Greater Adoption of Digital Therapeutics into Healthcare Systems" at LSX - partnering for Life Science eXecutives. An exchange stemming from the experiences of pioneers and experts, they discussed the challenges of DTx projects and best practices to scale and maximize their chances for success.   Couldn't attend? Read this guide with 8 tips on how to accelerate and de-risk digital therapeutics projects   https://lnkd.in/eB_WQJHd     #LSXUSA #DTx #HealthTech

OMG! We just got the news ZenZen Diabetes Support is selected in the TOP 20 Digital Diabetes Solution by Diabetes Center Berne! What a great company! What a challenge! We are so excited! Wish us luck to be selected in the TOP 3 in the next round! #startup #diabetescare #diabetes #diabetesmanagement #gestationaldiabetes #challange #innovation #makeachange

Startup Spotlight! Each year we are amazed by what our Eddies teams do! Explore the groundbreaking work of General Prognostics (GPx) revolutionizing how doctors can monitor their patients’ blood biomarkers remotely - without needles or implants. Learn more at https://gpx.ai/!

🚀 Fierce Biotech have announced their 15 companies of 2023! This is always a great read for anyone working in this space with innovation at the forefront! 🤝 Some companies on here are developing quickly and this year will determine their pathway to success with key milestones to be hit. Below, are the teams in the diagnostics space who received recognition. 🤖 Causaly - Using AI to parse and connect scientific discoveries. 🧬Element Biosciences - Taking next-gen sequencing beyond DNA. 👩🔬Karius - Rapid, noninvasive infection testing for the immunocompromised. 🧪Namida Lab, Inc. - Detecting breast cancer early with tear-based screening. 🩸Noah Medical - Charting a new course in lung cancer diagnostics. Read into them, some exciting missions and personal stories attached. #fierce15 #diagnostics

Our CEO Marc Jones is looking forward to participating in the below panel on #neurodegenerative diseases: the quest to make it a thing of the past. See everyone next week!